GRIA2 and Alzheimer disease: In particular, there was strong evidence for decreased levels of one type of glutamate receptor—AMPA receptors (evidenced by consistent decreases in three of the four protein subunits GRIA1, GRIA2 and GRIA3)—in advanced AD, but not in early-stage AD.